Research Projects and Clinical Trials
A number of clinical trials and research projects are conducted at the Alfred Health Radiation Oncology unit, ranging from departmental projects to international studies for a variety of different cancers. These studies are important in improving treatments and outcomes for patients.
If you meet the selection criteria to participate in a trial, you may be asked to discuss this option in more detail with your radiation oncologist and a member of our research team.
The current trials we have open are:
- Evaluation of neurocognition and quality of life in patients receiving stereotactic radiotherapy for brain metastases (StereoQ
- Double-blinded randomised trial of prophylactic dexamethasone versus placebo in stereotactic radiotherapy to 1-3 brain metastases (StereoDex)
- Randomised trial of adjuvant versus delayed stereotactic radiotherapy to resection cavity of brain metastases and quality of life outcomes (StereoCav)
- Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – a randomised phase III trial.
- RTN2 A Randomised Trial of Post Operative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck
- Focal Ablative Stereotactic RAdiosurgery for Cancers of the Kidney - A Phase II Clinical Trial (FASTRACK II)
- Treating metastatic melanoma with Stereotactic Ablative Radiotherapy and Immune Pathway Activation: A phase I dose-escalation trial (SABR-IMPACT)